Ubiquiti has delivered accelerating revenue and margin growth, driven by strong product launches. Read why I'm reiterating my ...
Trump, rescheduling, and the future of cannabis: chaos, risk, and opportunity as operators navigate federal change, markets, ...
2d
BioMarin: Valuation, Growth, And The Pipeline May Outweigh TransCon Competition And Regulatory Risks
BioMarin has both a solid revenue portfolio of several products and a promising pipeline. Click here to see why BMRN stock is ...
News-Medical.Net on MSN
Precision targeting of the centromedian nucleus offers hope for people with drug-resistant epilepsy
It is estimated that one-third of the 50 million people worldwide with epilepsy are resistant to anti-seizure medications. These patients, having drug-resistant epilepsy, have limited treatment ...
It is estimated that one-third of the 50 million people worldwide with epilepsy are resistant to anti-seizure medications. These patients, with drug-resistant epilepsy, have limited treatment options ...
Sydney Lai’s Gaia champions decentralized AI with local processing, token rewards, and governance to ensure data sovereignty.
KOMET-001 in R/R NPM1-m AML met its primary endpoint with ziftomenib monotherapy demonstrating significant clinical benefit and deep responses ...
For millennia, aging has been viewed as an immutable, inevitable decline. However, a scientific revolution is underway, ...
Meihua Liang and Yuting Chen of Commerce & Finance Law Offices present an analysis of China's distinct regulatory model governing digital assets, and its legal implications for market participants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback